Abstract
MTAN has been known to occur in a variety of bacterial cell types. Due to the evolution of bacterial strains which are resistant to some of the most powerful antibiotics there has been a renewed interest in the development of novel anti-microbial agents. Presented herein is a synthesis of a potent MTAN inhibitor, namely 2-amino-4-[5-(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)-3,4-dihydroxypyrrolidin-2-ylmethylsulfanyl]-butyric acid (1).
MeSH terms
-
Butyrates / chemical synthesis*
-
Butyrates / pharmacology*
-
Deoxyadenosines / antagonists & inhibitors*
-
S-Adenosylhomocysteine / antagonists & inhibitors*
-
Spectrophotometry, Ultraviolet
-
Thionucleosides / antagonists & inhibitors*
Substances
-
2-amino-4-(5-(4-amino-5H-pyrrolo(3,2-d)pyrimidin-7-yl)-3,4-dihydroxypyrrolidin-2-ylmethylsulfanyl)butyric acid
-
Butyrates
-
Deoxyadenosines
-
Thionucleosides
-
5'-methylthioadenosine
-
S-Adenosylhomocysteine